Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Immaculada Danes Carreras is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Estudio de utilización de antifúngicos sistémicos en los hospitales españoles
Danes Carreras, I. (Principal Investigator)
Institute of Health Carlos III (ISCIII)
1/11/07 → 31/12/09
Project: Entity with its own legal personality projects
Research output
- 14 Article
-
Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review
Sans Pola, C., Boy, R., Villar, A., Ojanguren, I., Simeón, C. P., Guillen-Del-Castillo, A., Vancells, G., Agusti Escasany, M. A. & Danes Carreras, I., Sept 2026, In: International Journal of Clinical Pharmacology and Therapeutics. 64, p. 459-469 11 p., 42233448.Research output: Contribution to journal › Article › Research › peer-review
-
Hospital admissions for acute drug poisoning in adults and children: a 7-year retrospective analysis of hospital discharges at a tertiary center
Wang, D., Camacho Arteaga, L. F., Muñoz Gallarín, R., Danes Carreras, I. & Agusti Escasany, M. A., 1 Oct 2025, In: Frontiers in Toxicology. 7, 11 p., 1672470.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk
Bosch Ferrer, M., Danes Carreras, I., Ballarín alins, E., Marrero, P., Vancells, G., Ortiz-Zúñiga, A., Urquizu-Padilla, M., Rial Lorenzo, N., Lozano Torres, J., Rodríguez Luna, D., Filippi-Arriaga, F. & Agusti Escasany, M. A., 18 Oct 2024, In: Med Clin (Barc). 163, 7, p. 317-322 6 p.Research output: Contribution to journal › Article › Research › peer-review
4 Link opens in a new tab Citations (Scopus) -
Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review
Sans Pola, C., Danes Carreras, I., Bosch Gil, J. A., Marrero-Alvarez, P., Cortes Hernandez, J. & Agusti Escasany, M. A., 25 May 2023, In: Frontiers in Medicine. 10, 12 p., 1159794.Research output: Contribution to journal › Article › Research › peer-review
Open Access18 Link opens in a new tab Citations (Scopus) -
Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review.
Amaro Hosey, K., Danes Carreras, I. & Agusti Escasany, M. A., 3 Feb 2022, In: Frontiers in Pharmacology. 12, 9 p., 777498.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Link opens in a new tab Citations (Scopus)
Thesis
-
Anàlisi de la utilització de medicaments en població pediàtrica i adulta. Utilització de medicaments en condicions no aprovades
Danés Carreras, I. (Author), Agustí Escasany, M. A. (Director) & Vallano Ferraz, A. (Director), 6 Nov 2015Student thesis: Doctoral thesis